Atea Pharmaceuticals, Inc.
AVIR · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $282,287 | $254,339 | $400,410 | $740,411 |
| - Cash | $64,696 | $143,823 | $188,460 | $764,375 |
| + Debt | $1,642 | $2,402 | $3,124 | $197 |
| Enterprise Value | $219,233 | $112,918 | $215,074 | -$23,767 |
| Revenue | $0 | $0 | $0 | $351,367 |
| % Growth | – | – | -100% | – |
| Gross Profit | -$83,367 | -$70,090 | -$62,390 | $184,162 |
| % Margin | – | – | – | 52.4% |
| EBITDA | -$131,800 | -$119,593 | -$110,844 | $138,406 |
| % Margin | – | – | – | 39.4% |
| Net Income | -$168,385 | -$135,956 | -$115,909 | $121,190 |
| % Margin | – | – | – | 34.5% |
| EPS Diluted | -2 | -1.63 | -1.39 | 1.37 |
| % Growth | -22.7% | -17.3% | -201.5% | – |
| Operating Cash Flow | -$135,499 | -$85,395 | -$120,982 | -$87,005 |
| Capital Expenditures | $0 | $0 | -$1,943 | -$4 |
| Free Cash Flow | -$135,499 | -$85,395 | -$122,925 | -$87,009 |